tiprankstipranks
Trending News
More News >
Diamedica Therapeutics (DMAC)
:DMAC
US Market
Advertisement

Diamedica Therapeutics (DMAC) Technical Analysis

Compare
543 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
5Neutral
1Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Diamedica Therapeutics’s (DMAC) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting Diamedica Therapeutics is a Buy.
Diamedica Therapeutics’s (DMAC) 20-Day exponential moving average is 6.79, while Diamedica Therapeutics’s (DMAC) share price is $6.88, making it a Buy.
Diamedica Therapeutics’s (DMAC) 50-Day exponential moving average is 6.42, while Diamedica Therapeutics’s (DMAC) share price is $6.88, making it a Buy.

Diamedica Therapeutics (DMAC) Pivot Points

Oct 27, 2025, 12:20 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.45
6.56
6.66
6.77
6.87
6.98
7.08
Fibonacci
6.56
6.64
6.69
6.77
6.85
6.90
6.98
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Diamedica Therapeutics (DMAC) Moving Averages

Oct 27, 2025, 12:20 PM
Period
Simple
Exponential
MA5
6.75Buy
6.78Buy
MA10
6.80Buy
6.79Buy
MA20
6.85Buy
6.79Buy
MA50
6.58Buy
6.42Buy
MA100
5.40Buy
5.84Buy
MA200
5.17Buy
5.48Buy
Diamedica Therapeutics’s (DMAC) 10-Day exponential moving average is 6.79, while Diamedica Therapeutics’s (DMAC) share price is $6.88, making it a Buy.
Diamedica Therapeutics’s (DMAC) 100-Day exponential moving average is 5.84, while Diamedica Therapeutics’s (DMAC) share price is $6.88, making it a Buy.
Diamedica Therapeutics’s (DMAC) stock price is $6.88 and Diamedica Therapeutics’s (DMAC) 50-day simple moving average is 6.58, creating a Buy signal.
Diamedica Therapeutics’s (DMAC) stock price is $6.88 and Diamedica Therapeutics’s (DMAC) 100-day simple moving average is 5.40, creating a Buy signal.
Diamedica Therapeutics’s (DMAC) stock price is $6.88 and Diamedica Therapeutics’s (DMAC) 200-day simple moving average is 5.17, creating a Buy signal.

Diamedica Therapeutics (DMAC) Technical Indicators

Oct 27, 2025, 12:20 PM
Name
Value
Implied Action
RSI (14)
53.58
Neutral
STOCH (9,6)
42.19
Neutral
STOCHRSI (14)
42.19
Neutral
MACD (12,26)
0.05
Buy
ADX (14)
15.66
Buy
Williams %R
-45.57
Buy
CCI (14)
-15.20
Neutral
ATR (14)
0.31
-
Ultimate Oscillator
44.88
Neutral
ROC
-0.72
Sell
Diamedica Therapeutics’s (DMAC) Relative Strength Index (RSI) is 53.58, creating a Neutral signal.
Diamedica Therapeutics’s (DMAC) Trend Strength Indicator (ADX) is 15.66, creating a Buy signal.
Diamedica Therapeutics’s (DMAC) Commodity Channel Index (CCI) is -15.20, creating a Neutral signal.
Diamedica Therapeutics’s (DMAC) Price Rate of Change (ROC) is -0.72, creating a Sell signal.

FAQ

Is DMAC a Buy, Hold, or Sell?
Based on DMAC’s technical indicators, DMAC is a Strong Buy.
    What is DMAC’s RSI (14)?
    DMAC’s RSI (14) is 53.58, which suggests DMAC is a Neutral.
      What is DMAC’s MACD?
      DMAC’s MACD is 0.05, which suggests DMAC is a Buy.
        What is DMAC’s 5-day moving average?
        DMAC’s 5-day moving average is 6.75, which suggests DMAC is a Buy.
          What is DMAC’s 20-day moving average?
          DMAC 20-day moving average is 6.85, which suggests DMAC is a Buy.
            What is DMAC’s 50-day moving average?
            DMAC’s 50-day moving average is 6.58, which suggests DMAC is a Buy.
              What is DMAC’s 200-day moving average?
              DMAC’s 200-day moving average is 5.17, which suggests DMAC is a Buy.
                What is DMAC’s Williams % R (14)?
                DMAC’s Williams % R (14) is -45.57, which suggests DMAC is a Buy.
                  What is DMAC’s CCI (14)?
                  DMAC’s CCI (14) is -15.20, which suggests DMAC is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis